Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1)

Clinical trial NCT06425055 · COMPLETED

Trial details

NCT number: NCT06425055
Sponsor: Enyo Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alport Syndrome

Start date: 2024-08-01
Primary completion: 2025-09-04
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.